Why the study?
What are the risks and benefits of nesiritide therapy in patients with acute decompensated heart failure?
Population
Patients with acute decompensated heart failure
Design
Review
Authors
Loading...
May warrant caution with nesiritide in acute decompensated HF; leaves open confirmation of risks in prospective RCTs.
What are the risks and benefits of nesiritide therapy in patients with acute decompensated heart failure?
Physicians must carefully reevaluate the use of nesiritide in acute decompensated heart failure due to safety concerns raised by recent meta-analyses, pending further trial data.
Rohit Arora (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: